Your search returned 1550 results.

Results
	161.	Acute demyelinating disease after interferon beta-1a treatment for multiple sclerosis. [electronic resource] by Von Raison, F Abboud, H Saint Val, C Brugières, P Césaro, P Producer: 20001222 In: Neurology vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	162.	Case series: ulcerative colitis, multiple sclerosis, and interferon-beta 1a. [electronic resource] by Rodrigues, S Magro, F Soares, J Nunes, A C R Lopes, S Marques, M Rio, E Macedo, G Producer: 20110331 In: Inflammatory bowel diseases vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	163.	Fulminant hepatic failure and autoimmune disorders in patient with multiple sclerosis on interferon beta 1a: a fatal combination? [electronic resource] by Pietrosi, Giada Mandala, Lucio Vizzini, Giovanni B Gruttadauria, Salvatore Minervini, Marta I Burgio, Gaetano Spadaro, Aldo Gridelli, Bruno Producer: 20080617 In: Transplant international : official journal of the European Society for Organ Transplantation vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	164.	Optimization of a high-throughput whole blood expression profiling methodology and its application to assess the pharmacodynamics of interferon (IFN) beta-1a or polyethylene glycol-conjugated IFN beta-1a in healthy clinical trial subjects. [electronic resource] by Allaire, Normand E Bushnell, Steven E Bienkowska, Jadwiga Brock, Graham Carulli, John Producer: 20130624 In: BMC research notes vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	165.	A Network Meta-Analysis of Efficacy and Evaluation of Safety of Subcutaneous Pegylated Interferon Beta-1a versus Other Injectable Therapies for the Treatment of Relapsing-Remitting Multiple Sclerosis. [electronic resource] by Tolley, Keith Hutchinson, Michael You, Xiaojun Wang, Ping Sperling, Bjoern Taneja, Ankush Siddiqui, Mohammed Kashif Kinter, Elizabeth Producer: 20160222 In: PloS one vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	166.	Interferon beta for multiple sclerosis. [electronic resource] by Connelly, J F Producer: 19940923 In: The Annals of pharmacotherapy vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	167.	Interferon beta-1B--hope or hype? [electronic resource] Producer: 19961217 In: Drug and therapeutics bulletin vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	168.	Commentary on neutralizing antibodies to interferon beta in patients with multiple sclerosis. [electronic resource] by Whitaker, J N Producer: 20010830 In: Archives of neurology vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	169.	Needed in MS: evidence, not EVIDENCE. [electronic resource] by Kieburtz, Karl McDermott, Michael Producer: 20021217 In: Neurology vol. 59 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	170.	Ibuprofen treatment versus gradual introduction of interferon beta-1b in patients with MS. [electronic resource] by Rice, G P Ebers, G C Lublin, F D Knobler, R L Producer: 19990715 In: Neurology vol. 52 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	171.	Cumulative effect of a weekly low dose of interferon beta 1a on standard and triple dose contrast-enhanced MRI from multiple sclerosis patients. [electronic resource] by Rovaris, M Capra, R Martinelli, V Gasperini, C Prandini, F Pozzilli, C Comi, G Filippi, M Producer: 20000203 In: Journal of the neurological sciences vol. 171 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	172.	[Immunologic therapy for secondary and primary progressive multiple sclerosis]. [electronic resource] by Ozawa, Kyoko Producer: 20031027 In: Nihon rinsho. Japanese journal of clinical medicine vol. 61 Availability: No items available. Save to lists Add to cart (remove)
	173.	Disease-modifying drugs for multiple sclerosis: current and future aspects. [electronic resource] by Freedman, Mark S Producer: 20061114 In: Expert opinion on pharmacotherapy vol. 7 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	174.	Long-term effect of IFN-beta 1a therapy on CCL2 (MCP-1) chemokine in patients with multiple sclerosis. [electronic resource] by Szczuciński, Adam Losy, Jacek Producer: 20040528 In: Folia neuropathologica vol. 42 Availability: No items available. Save to lists Add to cart (remove)
	175.	The development of systemic sclerosis in a female patient with multiple sclerosis following beta interferon treatment. [electronic resource] by Powell, A Myles, M L Yacyshyn, E Producer: 20090414 In: Clinical rheumatology vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	176.	Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode. [electronic resource] by Goodin, D S Bates, D Producer: 20100113 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	177.	Immunomodulatory agents for the treatment of relapsing multiple sclerosis: a systematic review. [electronic resource] by Galetta, Steven L Markowitz, Clyde Lee, Andrew G Producer: 20021122 In: Archives of internal medicine vol. 162 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	178.	Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. [electronic resource] by Fischer, J S Priore, R L Jacobs, L D Cookfair, D L Rudick, R A Herndon, R M Richert, J R Salazar, A M Goodkin, D E Granger, C V Simon, J H Grafman, J H Lezak, M D O'Reilly Hovey, K M Perkins, K K Barilla-Clark, D Schacter, M Shucard, D W Davidson, A L Wende, K E Bourdette, D N Kooijmans-Coutinho, M F Producer: 20010111 In: Annals of neurology vol. 48 Availability: No items available. Save to lists Add to cart (remove)
	179.	Multiple sclerosis: rationale for early treatment. [electronic resource] by Söderström, M Producer: 20040108 In: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology vol. 24 Suppl 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	180.	Overview of London trial of intramuscular interferon-beta Ia in primary-progressive multiple sclerosis. [electronic resource] by Miller, David H Leary, Siobhan M Thompson, Alan J Producer: 20041231 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 10 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 1550 results.